1-Jul-2026
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
Globe Newswire (Tue, 19-May 9:15 AM ET)
Merit Medical Sets Sights on Industry Growth at Bank of America Health Care Conference
Market Chameleon (Fri, 8-May 5:49 AM ET)
Merit Medical to Participate in the Bank of America Healthcare Conference
Globe Newswire (Fri, 8-May 9:25 AM ET)
Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance
Globe Newswire (Thu, 30-Apr 4:05 PM ET)
Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
Globe Newswire (Thu, 2-Apr 6:00 PM ET)
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Merit Medical Systems trades on the NASDAQ stock market under the symbol MMSI.
As of July 1, 2026, MMSI stock price climbed to $69.45 with 679,829 million shares trading.
MMSI has a beta of 0.22, meaning it tends to be less sensitive to market movements. MMSI has a correlation of 0.01 to the broad based SPY ETF.
MMSI has a market cap of $4.13 billion. This is considered a Mid Cap stock.
Last quarter Merit Medical Systems reported $382 million in Revenue and $.94 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.13.
In the last 3 years, MMSI traded as high as $111.45 and as low as $59.74.
The top ETF exchange traded funds that MMSI belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
MMSI has underperformed the market in the last year with a return of -25.7%, while the SPY ETF gained +21.9%. In the last 3 month period, MMSI fell short of the market, returning +1.2%, while SPY returned +18.3%. However, in the most recent 2 weeks MMSI has outperformed the stock market by returning +2.6%, while SPY returned -0.4%.
MMSI support price is $67.96 and resistance is $70.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MMSI shares will trade within this expected range on the day.